Anti-Sortilin Antibodies and Methods of Use Thereof (2016)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application PCT/US2016/026519, filed Apr 7, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,087,255 | Anti-Sortilin Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | ||
| US 10,308,718 | Anti-Sortilin Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | ||
| US 10,428,150 | Anti-Sortilin Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | ||
| US 11,208,488 | Methods of Increasing Progranulin Levels Using Anti-Sortilin Antibodies In force · High confidence | Alector LLC | In force | High confidence | ||
| US 11,339,223 | Methods of Use of Anti-Sortilin Antibodies for Treating a Disease, Disorder, or Injury In force · High confidence | Alector LLC | In force | High confidence | ||
| US 11,186,645 | Isolated Nucleic Acids Encoding Anti-Sortilin Antibodies In force · High confidence | Alector LLC | In force | High confidence | ||
| Application 17/534,270 | Methods of Use of Anti-Sortilin Antibodies for Treating a Disease, Disorder, or Injury Abandoned Abandoned Jan 3, 2025 | Alector LLC | Abandoned | Abandoned Jan 3, 2025 | not computed | |
| Application 17/534,291 | Methods of Increasing Progranulin Levels Using Anti-Sortilin Antibodies Abandoned Abandoned Feb 6, 2025 | Alector LLC | Abandoned | Abandoned Feb 6, 2025 | not computed | |
| Application 17/721,112 | Methods of Use of Anti-Sortilin Antibodies for Treating a Disease, Disorder, or Injury Abandoned Abandoned Mar 10, 2025 | Alector LLC | Abandoned | Abandoned Mar 10, 2025 | not computed | |
| Application 18/957,413 | Methods of Use of Anti-Sortilin Antibodies for Treating a Disease, Disorder, or Injury Pending Not granted | Alector LLC | Pending | Not granted | not computed |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Alector LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.